SBIR/STTR Research Award
NEW DRUGS FOR THE TREATMENT OF BREAST CANCER
Award amount
$100,378Program and phase
SBIR · Phase IAward year
1999Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- THEREX TECHNOLOGIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available The dispersal of special nuclear material (SNM) from US nuclear weapons has been given high level attention from the executive and legislative branches of government since the early 1990s. The studies and assessments to date have focused on abnormal environments initiated by accidents during normal peacetime military operations. These studies have identified some abnormal environments in which disposal is likely to occur. These environments can be initiated by accident or intentionally by terrorists. Dispersal by intentional means is likely to have the same health and political consequences with respect to public consequences as dispersal by accidental means. Phase I research will develop a methodology to assess intentional actions such that the quantified risk of these actions is comparable with the risk quantified by accepted methods for accidents. The specific objectives are to assess the likelihood and effectiveness of a terrorist attack and support their integration into DTRA's Nuclear Weapon System Safety Assessment.
Technology keywords
Not reported